Knapen, Lotte M. http://orcid.org/0000-0002-8858-4711
Koornstra, Rutger H. T.
Driessen, Johanna H. M.
van Vlijmen, Bas
Croes, Sander
Schalkwijk, Stein
Colbers, Angela
Gerritsen, Winald R.
Burger, David M.
de Vries, Frank
van Erp, Nielka P.
Funding for this research was provided by:
Maastricht University Medical Center
Article History
First Online: 11 April 2018
Compliance with Ethical Standards
:
: No external funding was used in the preparation of this manuscript. This article was published open access under a Springer Compact agreement with Dutch universities and Academy institutes.
: LK, JD, BvV, SC, SS, and FdV declare that they have no conflicts of interest that might be relevant to the contents of this manuscript. RK received consultancy fees from MSD, BMS, and Novartis and research funding from BMS and Roche. AC received research funding from BMS, Merck, Viiv, and Janssen. WG received speaker fees from Bayer and MSD, consultancy fees from Bristol-Myers Squibb, Astellas, Janssen-Cilag, Bayer, Sanofi, Amgen, Morphosys, CureVac, and Aglaia Biomedical Ventures, and research funding from Bayer, Astellas, and Janssen-Cilag. DB received research funding from BMS, Viiv, and Janssen. NvE received research funding from Novartis, Janssen-Cilag BV, Astellas, Gilead, Boehringer-Ingelheim, Pfizer, AstraZeneca, and Sanofi. All fees and funding were received outside the context of the submitted work.